How do you incorporate next gen sequencing results into your management of pediatric patients with B-ALL who have not been transplanted?

With the new COG leukemia studies, it is difficult to interpret these results in the context of their clinical status and conventional MRD

Answer from: at Academic Institution

We enroll in the EndRAD SCT trial which is guided by NGS results.

Comments

at Washington University in St. Louis
This only applies to patients who are transplanted...